Clinical Trials in Houston

Showing 10441-10460 of 17,885 trials

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

NCT00006360

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.

Head and Neck CancerRadiation Toxicity

Radiation Therapy Oncology GroupStarted Feb 2001

Phoenix, Arizona, United States • San Francisco, California, United States • Gainesville, Florida, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

NCT00006366

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy plus chemotherapy is more effective for rectal cancer. PURPOSE: Randomized phase II trial to compare two regimens of radiation therapy plus chemotherapy followed by surgery in treating patients who have locally advanced cancer of the rectum.

Colorectal Cancer

Radiation Therapy Oncology GroupStarted Feb 2001

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +232 more locations

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Find Trials by Condition in Houston

An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)

Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

National Marrow Donor Program Long-Term Donor Follow-Up

Evaluation of CRB in PROM Patients

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

Sustainable HIV Risk Reduction Strategies for Probationers

To Study the Effect of Early Cooling in Acute Subdural Hematoma Patients

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

Folate Rechallenge

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy

A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

One Week Aligner Evaluation

Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma